Combination of High-Dose Methylprednisolone and Defibrotide for Veno-Occlusive Disease in Pediatric Hematopoietic Stem Cell Transplant Recipients

被引：0
|
作者：
Gloude, Nicholas [1 ]
Jodele, Sonata [1 ]
Teusink-Cross, Ashley [1 ]
Grimley, Michael [1 ]
Davies, Stella [1 ]
Myers, Kasiani [1 ]
机构：
[1] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
来源：
PEDIATRIC BLOOD & CANCER | 2017年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
607
引用
收藏
页码：S55 / S55
页数：1
相关论文
共 50 条
  • [41] Hepatic veno-occlusive disease following hematopoietic stem cell transplantation
    Richardson, P
    Guinan, E
    ACTA HAEMATOLOGICA, 2001, 106 (1-2) : 57 - 68
  • [42] Veno-occlusive disease in paediatric stem cell recipients:: risk factors, prophylaxis and therapy with antithrombin III concentrates and defibrotide
    Haussmann, U
    Eber, S
    Fischer, J
    Seger, R
    Güngör, T
    BONE MARROW TRANSPLANTATION, 2005, 35 : S262 - S262
  • [43] DEFIBROTIDE FOR THE PREVENTION AND TREATMENT OF HEPATIC VENO-OCCLUSIVE DISEASE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION; A SINGLE CENTER EXPERIENCE
    Antmen, B.
    Sasmaz, I.
    Karagun, B.
    Serbest, M.
    HAEMATOLOGICA, 2016, 101 : 628 - 628
  • [44] Defibrotide for the prevention and treatment of hepatic veno-occlusive disease after hematopoietic stem cell transplantation; A single center experience
    Antmen, B.
    Sasmaz, I.
    Karagun, B.
    Serbest, M.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S215 - S216
  • [45] Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies
    Ho, V. T.
    Revta, C.
    Richardson, P. G.
    BONE MARROW TRANSPLANTATION, 2008, 41 (03) : 229 - 237
  • [46] DEFIBROTIDE FOR THE PREVENTION AND TREATMENT OF HEPATIC VENO-OCCLUSIVE DISEASE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION; A SINGLE CENTER EXPERIENCE
    Antmen, B.
    Sasmaz, I.
    Karagun, B.
    Serbest, M.
    HAEMATOLOGICA, 2017, 102 : 623 - 623
  • [47] Defibrotide for the prevention and treatment of hepatic veno-occlusive disease after hematopoietic stem cell transplantation; A single center experience
    Antmen, B. A.
    Sasmaz, I.
    Karagun, B.
    Serbest, M.
    Ucar, G.
    Baysal, T.
    BONE MARROW TRANSPLANTATION, 2015, 50 : 5580 - 5580
  • [48] The experience of using defibrotide for the prevention and treatment of hepatic veno-occlusive disease after pediatric hematopoietic stem cell transplantation: A single center experience
    Antmen, Bulent
    Sasmaz, Ilgen
    Karagun, Barbaros
    Serbest, Murat
    BONE MARROW TRANSPLANTATION, 2018, 53 : 727 - 727
  • [49] Successful therapy of transplant-associated veno-occlusive disease with a combination of tissue plasminogen activator and defibrotide
    Jenner, MJ
    Micallef, INM
    Rohatiner, AZ
    Kelsey, SM
    Newland, AC
    Cavenagh, JD
    MEDICAL ONCOLOGY, 2000, 17 (04) : 333 - 336
  • [50] Defibrotide prophylaxis of Veno-Occlusive disease in children with High-Risk Neuroblastoma treated with Busulfan-Melphalan High-Dose Chemotherapy and Autologous Stem Cell Transplantation
    Pasqualini, C.
    Cros, G.
    Dufour, C.
    Abbou, S.
    Dourthe, M. -E.
    Rigaud, C.
    Valteau-Couanet, D.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S260 - S260
12345